Chapter 15: CNS Stimulants

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, it's like a universal college experience.

You wake up, your brain feels like it's wrapped in thick wool and you can barely string a sentence together.

Oh yeah, totally.

So you stumble into the kitchen, you brew a cup of coffee and within 20 minutes the fog lifts.

You're alert.

You're ready to tackle the day.

We treat that morning cup of coffee like it's just this comforting routine.

Right, but underneath you just initiated a highly specific targeted chemical intervention in your brain.

Exactly.

I mean, it really is a profound physiological shift and we completely take it for granted.

You've essentially just administered a central nervous system stimulant.

Millions of people are self -medicating every single morning without actually knowing the underlying chemistry.

And that chemistry is exactly what we are unpacking today.

If you are a college student seeing pharmacology for the very first time or, you know, if you're just insanely curious about what that latte is doing to your neurons, this deep dive is for you.

Yeah, it's going to be fun.

We're acting as your last -minute lecture team today and our mission is to tackle Chapter 15 of Lippincott Illustrated Reviews, Pharmacology.

We are focusing entirely on central nervous system, or CNS, stimulants.

It's a fascinating territory because it spans everything from that morning cup of coffee to highly restricted drugs of abuse.

To understand it, it helps to visualize two main cams of stimulants, which the text lays out right away in Figure 15 .1.

Right, the big overview map.

Exactly.

So first, you have the psychomotor stimulants.

These are the drugs that cause excitement, euphoria, decrease your feelings of fatigue,

and actively increase your motor activity.

They basically rev the physical engine.

You can picture a spectrum here for this first camp.

Yeah, a huge spectrum.

On one end, you have everyday over -the -counter items like caffeine and nicotine.

Then you slide all the way up to intense clinical drugs and schedule two restricted substances.

So your amphetamines, your cocaine.

It's a massive range of intensity, but they all fall under that psychomotor umbrella.

Then you have the second camp.

The hallucinogens.

Which are totally different, right?

Completely.

These don't just speed things up, they produce profound changes in thought patterns and mood, with surprisingly little effect on the brain stem and spinal cord.

We'll touch on those later.

But to understand how the heavy -hitting clinical drugs work, it makes sense to start with the baseline.

Let's look at the stimulant that most of us have in our system right now.

The methylxanthines.

Yes, let's talk about the methylxanthines.

That's the chemical family.

It includes theophylline, which you find in tea, and theobromine, which is found in cocoa.

But the absolute heavy -hitter of the group is kaifon.

Right.

Coffee, colas, energy drinks.

It is the most widely consumed stimulant in the world.

So how is it actually waking us up?

Well, it's all about blocking a specific signal.

I always picture it like a piece of duct tape.

If your brain has a chemical time -to -sleep signal that builds up over the day, caffeine is just taping over the sensor.

That is a perfect analogy.

The time -to -sleep signal you're talking about is a molecule called adenosine.

One of the primary mechanisms for methylxanthines is the blockade of those adenosine receptors.

So it just gets in the way.

Exactly.

The caffeine molecule fits perfectly into the receptor lock, but it doesn't turn the It just sits there, blocking the actual adenosine from getting in.

So the brain literally can't hear its own signal that it's tired.

That's a huge part of it, yeah.

But the mechanism of action is actually multi -pronged.

Methylxanthines also cause the translocation of extracellular calcium, and crucially, they inhibit an enzyme called phosphodesterase.

Okay, I have to stop you there.

Because whenever I hear a word like phosphodesterase inhibition, my eyes just start to glaze over.

What is that enzyme actually doing in plucker English?

Fair enough.

Let's think of your cells as having little internal messengers.

Specifically, molecules called cyclic AMP and cyclic GMP.

Okay, the messengers.

Right.

Phosphodesterase is the enzyme that normally sweeps in and breaks those messengers down.

It's the cleanup crew, keeping cellular activity in check.

Oh, I see.

By inhibiting that cleanup enzyme, caffeine causes a massive artificial traffic jam of those messengers.

The cyclic AMP and cyclic GMP pile up, which ramps up cellular activity across the board.

And that cellular activity translates to what we actually feel physically.

The pharmacology text breaks down this dose -dependent response, which is fascinating.

It really is.

If you have 100 to 200 milligrams, that's your standard one or two cups of coffee,

it hits the cortex, it decreases fatigue and increases mental alertness.

You just feel sharp.

But push that to 1 .5 grams, which is about 12 to 15 cups of coffee, and the effects change dramatically.

Yeah, you aren't just more alert at that point.

No, not at all.

You start experiencing serious anxiety and tremors.

The spinal cord itself is only stimulated at very high doses, around 2 to 5 grams.

And it doesn't just stay in the brain either.

There are peripheral effects all over the body.

It has a mild diuretic action, so increasing the urinary output of sodium, chloride, and potassium.

Plus, it stimulates the cardiovascular system.

At high doses, caffeine has positive inotropic and chronotropic effects.

Remind me what those mean again?

Sure.

So, inotropic means it increases the actual physical force of the heart's contraction.

Chronotropic means it increases the heart rate.

This is why high doses can actually trigger premature ventricular contractions.

And that increased contractility can be genuinely harmful to patients with angina.

Wow.

There's another really practical clinical takeaway here regarding the stomach too.

Methylxanathines stimulate the secretion of gastric acid.

Yes, the GI effects.

I've known so many people who drink black coffee on an empty stomach and complain about heartburn.

If someone has a peptic ulcer, that morning espresso is basically just pouring acid onto an open wound.

A completely avoidable irritation, yeah.

And from a pharmacokinetic standpoint, caffeine is well absorbed orally and distributes everywhere.

It crosses right into the brain.

And how does the body get rid of it?

Your liver has a specific chemical assembly line called the CIP1A2 pathway dedicated to breaking it down.

It's also critical to note that it crosses the placenta to the fetus and is secreted into breast milk.

Which brings up a very relatable question.

Because coffee is so normalized, we forget it causes actual physical dependence.

It definitely does.

What actually happens in the body if you just quit cold turkey?

Well, if a user routinely consumes more than 600 milligrams a day, roughly six strong cups of coffee, and then suddenly stops, they will experience a very real withdrawal syndrome.

So headaches and grumpiness.

Severe lethargy, extreme irritability, and a throbbing headache.

Tolerance develops rapidly to the stimulating properties, meaning your baseline shifts just to feel normal.

And just to touch on the extreme end of toxicity, the theoretical lethal dose of caffeine is 10 grams.

That's about 100 cups of coffee, which induces fatal cardiac arrhythmias.

So respect the coffee bean.

Now, caffeine might be the most widely consumed stimulant, but the second most widely used is also the second most abused drug overall, right behind alcohol.

And that brings us to nicotine.

Nicotine is the active ingredient in tobacco.

And outside of smoking cessation therapy, it has absolutely no therapeutic use.

None at all.

But pharmacologically, it is incredibly important to understand because of the sheer scale of its use and its role in lung and cardiovascular disease.

The mechanism is wild because it's highly lipid soluble.

It just effortlessly slips right across the blood brain barrier.

Yeah, it gets right in.

But here's where it gets really interesting.

And I have to point out what looks like a massive contradiction here.

OK, let's hear it.

I know people who smoke to wake up and people who smoke to calm down.

How can a single chemical cause a smoker to feel both arousal and relaxation at the same time?

It does seem paradoxical, but it comes down to a dose dependent mechanism.

It acts on nicotinic receptors in the central nervous system and the peripheral ganglia.

Figure 15 .2 illustrates this beautifully.

Walk us through that.

In low doses, like what you get from a typical drag on a cigarette nicotine, causes ganglionic stimulation by depolarization.

This produces euphoria, arousal, and improves attention and reaction time.

That's your stimulant effect.

OK, but what about the relaxation part?

Well, the relaxation is partly just psychological relief from the very early stages of withdrawal.

But the physiological catch is what happens at higher doses.

At high doses, nicotine causes ganglionic blockade.

It overstimulates the receptor to the point where the receptor just shuts down entirely.

Whoa, really?

Yeah, the contrast is stark.

Low doses give you that arousal, but high doses lead to severe hypotension and can even cause central respiratory paralysis.

Meaning it shuts down the breathing center in the brain.

Exactly.

That is a terrifying shift.

And the peripheral effects are just a mess of contradictions, too.

It stimulates the sympathetic ganglia, which increases heart rate and blood pressure.

Which is why it is so uniquely dangerous for patients with hypertension or angina,

is actively decreasing coronary blood flow through vasoconstriction while simultaneously forcing the heart to work harder.

But then, at the exact same time, it stimulates the parasympathetic ganglia, which increases the motor activity of your bowel.

Right, it's hitting the gas pedal on both the fight or flight and the rest can digest systems simultaneously.

It just throws the body's natural rhythms into chaos.

And because of that, the withdrawal is brutal.

The text has this chart, figure 15 .3, mapping it out.

The physical dependence develops rabidly, leading to severe insomnia, splitting headaches, and intense irritability when the drug is removed.

This is where understanding the pharmacokinetics, how the drug moves through the blood over time, becomes crucial for anyone trying to quit.

Let's talk about figure 15 .4, then.

It shows these different blood nicotine levels based on how you take it.

Right, so when someone smokes a cigarette, they get a massive, immediate, almost violent spike in blood nicotine levels, followed by a rapid crash.

The peak is so sharp.

That violent spike is exactly what drives the addictive reward pathway in the brain.

And the subsequent crash is what triggers the overwhelming craving for another cigarette.

So if you want to help someone quit, you obviously can't just give them more spikes.

No, that defeats the purpose.

That's why nicotine ewing gum provides a low, rolling, steady wave in the blood.

The peak is only about half as high as smoking.

And the transdermal patch is even more gradual looking at the graph.

It's just a very slow, sustained baseline over hours.

The goal of the patch in the gum isn't to provide a high.

It's to provide just enough of a baseline to stop the withdrawal symptoms without giving that massive dopamine spike that reinforces the addiction.

Which makes sense.

But there is a very specific, fascinating clinical solution for quitting called barenicline.

Barenicline is brilliant.

Pharmacology classifies it as a partial agonist at neuronal nicotinic acetylcholine receptors.

If nicotine floods the receptors and quitting starves them, I think of a partial agonist like a dimmer switch in a dark room.

That dimmer switch analogy holds up perfectly.

Nicotine is a full agonist.

It flips the light switch all the way on, blasting the room with light, creating that intense euphoria.

And if you quit cold turkey, the lights are just off, the room is pitch black, and that's the misery of withdrawal.

Exactly.

But barenicline turns that dimmer switch up just enough so you aren't stumbling around in the dark.

It produces far less euphoric effect than nicotine, which prevents the severe withdrawal.

But it physically occupies those receptors, right?

Yes.

So even if the patient does smoke a cigarette in a moment of weakness, the nicotine can't get to the receptor to flip the switch to full blast.

The barenicline is already sitting there.

It's an elegant mechanism.

But you do have to monitor patients taking it very closely.

Messing with fundamental neurotransmitter pathways comes with risks.

Furious risks, yeah.

Specifically suicidal thoughts, vivid nightmares, and severe mood changes.

And speaking of altering those pathways, while nicotine causes massive dependence, its euphoric effects pale in comparison to our next category.

Oh, absolutely.

We are moving into schedule two territory now.

Drugs that directly and violently hijack the brain's pleasure center.

We are talking about cocaine.

It is highly addictive, widely available, and its mechanism is entirely different from the receptor blocking of caffeine or the receptor mimicking of nicotine.

Very different.

So what is exactly happening in the brain to create such intense euphoria?

It comes down to trapping the transmitters.

Normally, your brain releases monoamines, specifically norepinephrine, serotonin, and dopamine,

into the synaptic space between neurons to send a signal.

OK, signal sent.

Then what?

Once the signal is successfully sent, little vacuum cleaners on the presynaptic terminal, called reuptake transporters, suck the neurotransmitters back up to be recycled.

They clean up the chemical mess so the signal stops and the brain can reset.

Cocaine physically blocks those vacuum cleaners.

Its primary mechanism of action is the blockade of reuptake of these monoamines.

So it's like throwing a massive party in the brain's synaptic cleft, specifically in the limbic system, which acts as the brain's pleasure center, and then locking all the doors so the neurotransmitters can't leave.

They just keep bouncing around, hitting the receptors over and over and over.

That continuous, prolonged dopaminergic stimulation is what produces the intense, overwhelming euphoria.

But there is an inevitable devastating consequence.

The crash.

Figure 15 .5 illustrates this dynamic perfectly.

Right, because if you lock the doors and don't let the transmitters get recycled back into the terminal,

eventually, well, the terminal just runs dry.

Chronic intake of cocaine severely depletes the brain's dopamine stores.

The presynaptic terminal literally has nothing left to release.

It's empty.

This severe depletion is what triggers the overwhelming physical craving.

The brain is physiologically starved of dopamine.

So if cocaine works by locking neurotransmitters in the synaptic space, this raises a really interesting connecting question.

Okay, what's that?

What happens if a drug doesn't just lock the doors, but actively forces more neurotransmitters into the space to begin with?

Ah, then you have the mechanism of the amphetamines.

And this is where the cellular mechanics get absolutely chaotic.

Let's look at Figure 15 .6.

It is a profound disruption.

Amphetamines are indirect -acting sympathetic amines.

Unlike cocaine, which just sits on the outside of the neuron blocking the vacuum, amphetamine actually enters the presynaptic terminal.

It goes right inside.

Yes.

And once inside,

it actively forces the release of intracellular stores of catecholamines right into the synapse.

So it turns the faucet on full blast.

It does, but it doesn't stop there.

It also inhibits monoamine oxidase, or MAO, which is the enzyme that usually breaks down excess neurotransmitters.

Oh, wow.

And on top of that, it acts as a weak reuptake inhibitor itself.

So it forces the release, stops the chemical breakdown, and blocks the recycling.

It's a triple threat.

The result is dangerously high levels of catecholamines flooding the synaptic spaces.

And despite this incredibly powerful explosive mechanism, we use these clinically.

That always surprises people seeing this for the first time.

We do use them, but with extreme caution due to the psychological and physiological dependence.

The most prominent therapeutic use is for attention deficit hyperactivity disorder, or ADHD.

Which, I mean, it feels like a glaring logical fallacy.

How do you take a hyperkinetic child who can't sit still and calm them down by giving them a powerful stimulant?

He's a fascinating quirk of neurology.

Children with ADHD may actually produce incredibly weak dopamine signals.

So they are under -stimulated.

Exactly.

Because a signal is weak,

normally interesting activities or tasks don't provide enough baseline reward to hold their attention.

They become hyperactive, constantly seeking that missing stimulation.

That makes so much sense.

By giving them dextroamphetamine, methamphetamine, mixed amphetamine salts, or methylphenidate, you boost those weak signals.

Suddenly, the math homework in front of them provides enough dopamine to hold their focus.

That reframes it perfectly.

It's not about giving them energy.

It's about giving their brain the chemical satisfaction it needs to stop searching for distractions.

Precisely.

There's also a really cool pharmacological trick used for ADHD called Lisdexamphetamine, better known as Vivance.

Lisdexamphetamine is brilliant because it's a pro -drug.

That means the pill you swallow is totally inactive.

Wait, really?

It does nothing.

Nothing on its own.

Yeah.

It only becomes active when it is metabolized by the hydrolytic actions of your own red blood cells, which cleave it into L -lysine and the active dextroamphetamine.

So it's inactive until the body's red blood cells physically unlock it.

That naturally slows down the release over the day.

And I imagine it significantly lowers the abuse potential because you can't just crush it up and snort it to get a high.

The red blood cells have to do the work.

That's the exact reason it was designed that way.

There is also a non -stimulant option used for ADHD called Adamoxetine.

How does that one work?

It is highly selective for inhibiting norepinephrine reuptake rather than dopamine.

Because it doesn't flood the limbic system with dopamine, it's not considered habit forming and is not a controlled substance.

So that's ADHD.

The second major clinical use for amphetamines is narcolepsy, the sleep disorder characterized by uncontrollable bouts of daytime sleepiness.

Though for narcolepsy, the first -line agents are actually monafenol, and its derivative are modafenol.

They promote wakefulness,

but crucially they produce less of the psychoactive euphoric effects typical of classic amphetamines.

And the third clinical use is obesity, acting as an appetite suppressant.

Right.

Drugs like fenermyne work on the lateral hypothalamic feeding center to suppress appetite.

But again, these are tightly controlled because the adverse effects of this entire class are severe.

Let's talk about those side effects.

Because flooding the nervous system takes a huge toll.

Figure 15 .7 has this grim collage of symptoms.

You see virgo, dangerous spikes in blood pressure, severe insomnia, confusion, and massive GI distress like nausea and diarrhea.

You have to remember why the diarrhea happens.

You are flooding the sympathetic nervous system, throwing the body's natural rest and digest rhythms entirely offline.

Your body just panics.

The central nervous system effects are profound too.

Insomnia, irritability, tremors, panic states.

Importantly, chronic amphetamine use can produce a state called amphetamine psychosis.

Which sounds intense.

It is.

It clinically resembles the psychotic episodes associated with schizophrenia.

There's a really interesting clinical intervention regarding overdose in the text too.

If a patient comes into the ER with severe agitation from an amphetamine or cocaine overdose, how do you treat them?

You don't use another stimulant, obviously.

Definitely not.

You use a bendodiazepine, specifically lorazepam.

Bendodiazepines are the drugs of choice to manage that severe CNS stimulation and agitation because of their strong, calming anxiolytic and hypnotic properties.

There's also a great pharmacokinetic quirk regarding excretion.

Amphetamine is absorbed from the GI tract and excreted in the urine.

But if you alkalinize the urine, say by administering sodium bicarbonate, you change how the drug behaves in the kidneys.

By alkalinizing the urine, you increase the 9 -ionized species of the drug.

What does that mean in plain English?

It means the drug slips right back through the kidney walls.

It gets reabsorbed from the renal tubules right back into the bloodstream, prolonging its effects on the body.

It's a critical drug interaction for clinicians to be aware of.

Okay, so we've talked about the amphetamine class for ADHD, but there is a closely related specific drug that parents and students probably hear about the most.

Methylphenidate.

Methylphenidate, widely known as Ritalin, has CNS stimulant properties very similar to amphetamine.

It's a dopamine and norepinephrine transport inhibitor.

So another vacuum blocker.

Essentially, yes.

It blocks the reuptake, increasing the concentration of both neurotransmitters in the synaptic cleft.

It's a schedule II controlled substance, just like amphetamine.

And its active isomer, dexmethylphenidate, is also used.

Now think about a practical clinical scenario here.

You have a 10 -year -old kid with ADHD.

The oral pill works great in the morning, but it wears off.

The kid and the parents hate that he has to go to the school nurse in the middle of the day for a second dose.

It's disruptive to his learning, and it singles him out.

What's the pharmacological solution?

The solution is a change in the delivery system.

You use methylphenidate in a transdermal patch.

Just like the nicotine patch.

Very similar concept.

It's designed for once -daily application,

slowly releasing the drug throughout the day so the child doesn't ever need that midday dose at school.

That is such an elegant translation of pharmacokinetics into a patient's actual quality of life.

But of course, it's not without risks.

The adverse effects are very similar to amphetamines.

GI issues like abdominal pain and nausea are common.

It causes anorexia, insomnia.

And some serious contraindications, right?

Yes.

Crucially, in patients with epilepsy, methylphenidate lowers the seizure threshold, meaning it may increase seizure frequency.

And it is completely contraindicated in patients with glaucoma.

It also messes with liver metabolism.

It can inhibit the metabolism of some major life -saving drugs like warfarin, phenytoin, phenobarbital, and tricyclic antidepressants.

Which is incredibly dangerous.

If those drugs aren't being broken down, they build up to toxic levels, so you have to monitor those blood levels closely.

Now we mentioned at the very beginning that there is a second major category of CNS stimulants, the hallucinogens.

Right, and this is a completely different experience.

We aren't talking about physical speed or pinpoint focus anymore.

No, not at all.

Drugs like LSD and tetrahydrocannabinol or THC for marijuana don't just dump dopamine to rev the engine.

Their primary action is the ability to induce altered perceptual states that are reminiscent of dreams.

We are talking about visions of bright colors,

plasticity of constantly changing shapes, and altered sensory processing.

Fundamentally, the individual under the influence of these drugs is often incapable of normal decision -making because the drug actively interferes with rational thought.

It just rewires the processing.

Exactly.

It alters how the brain processes reality itself.

It's a completely different neurochemical manipulation.

Wow.

We've taken an incredible journey today.

We started with the gentle adenosine blockade from your morning coffee, navigated the complex biphasic traps of nicotine, explored how cocaine locks the doors on dopamine, and finally saw how amphetamines and methylphenidate flood the system to either create devastating addiction or provide the focus a child needs to succeed.

It really highlights the delicate balance of our neurochemistry.

Every single one of these profound psychological and physical changes comes down to just a few tiny molecules in the synaptic cleft.

It's mind -blowing.

They're merely mimicking, blocking, or forcing the release of what our bodies already produce naturally.

And here is a final thought for you to mull over.

We've spent this whole time talking about how these drugs affect humans.

But have you ever stopped to wonder why the coffee shrub or the tobacco plant evolved these highly complex neuromodulators in the first place?

They certainly didn't evolve them for us.

No, they didn't.

In nature, caffeine and nicotine are highly toxic natural pesticides.

They evolve to paralyze the nervous systems of insects that try to eat the leaves.

We are literally taking natural bug spray, tweaking the dose, and using it to study for exams.

It's a fascinating matter of evolutionary perspective, really.

So tomorrow morning when you are groggy and you reach for that cup of coffee, just remember, you aren't just waking up.

You are drinking an ancient defense mechanism to selectively put tape over your brain's sleep sensors.

Thank you so much for joining us on this deep dive.

From everyone here on the Last Minute Lecture team, good luck with your studying and we'll catch you next time.

β“˜ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Central nervous system stimulants function by enhancing neural activity and arousal through diverse pharmacological mechanisms, and they fall into two primary categories based on their behavioral effects. Psychomotor stimulants elevate alertness, increase motor activity, and produce euphoria, whereas hallucinogens primarily alter perception and cognition with limited impact on the brainstem and spinal cord. Understanding the mechanisms, clinical applications, and abuse potential of these agents is essential for healthcare providers managing conditions ranging from attention deficit hyperactivity disorder to narcolepsy. The methylxanthine class, which includes caffeine, theophylline, and theobromine, works through adenosine receptor antagonism and phosphodiesterase inhibition to promote wakefulness and cognitive function, though tolerance develops readily and high doses produce anxiety and cardiac effects. Nicotine exerts its effects through ganglionic receptor stimulation and produces potent addiction through dopamine pathway activation, while varenicline serves as a partial agonist that reduces the rewarding effects of nicotine for smoking cessation. Cocaine and amphetamines share the capacity to elevate synaptic monoamines, but they achieve this through distinct mechanisms: cocaine blocks reuptake transporters while amphetamines release intracellular catecholamine stores and inhibit monoamine oxidase. Amphetamine derivatives find legitimate therapeutic applications in attention deficit hyperactivity disorder, narcolepsy, and weight management, yet they carry substantial risks of addiction, tolerance, and cardiovascular complications. Methylphenidate similarly acts as a dopamine and norepinephrine transport inhibitor for attention and wakefulness disorders but requires monitoring for gastrointestinal adverse effects and drug interactions. Hallucinogens such as lysergic acid diethylamide and tetrahydrocannabinol induce profound alterations in sensory perception and thought processes, fundamentally impairing rational decision making. All stimulant medications demand careful patient selection, dose titration, and ongoing assessment due to their substantial potential for dependence, tolerance development, and serious systemic complications affecting cardiovascular and neurological function.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML β™₯